🔗 Share this article

Chancellor Rachel Reeves has stated she is planning "focused action to address cost of living issues" in next month's financial statement.

In comments to media outlets, she stated that curbing price rises is a joint duty of both the government and the central bank.

The United Kingdom's inflation rate is expected to be the most elevated among the Group of Seven industrialized countries this calendar year and next.

Possible Utility Cost Interventions

Sources suggest the government could take action to reduce energy bills, such as by cutting the current 5% rate of value-added tax charged on energy.

An additional option is to reduce some of the government charges currently included in household expenses.

Fiscal Limitations and Analyst Predictions

The administration will obtain the latest report from the official forecaster, the OBR, on the start of the week, which will show how much room there is for these actions.

The consensus from most experts is that Reeves will have to declare higher taxes or expenditure reductions in order to adhere to her self-imposed debt limits.

Earlier on Thursday, estimates suggested there was a £22 billion shortfall for the chancellor to fill, which is at the more modest range of projections.

"There's a joint job between the central bank and the government to continue tackling some of the causes of inflation," Reeves told reporters in Washington, at the conferences of the IMF and World Bank.

Tax Commitments and International Issues

While much of the attention has been on probable tax rises, the Treasury chief said the latest figures from the fiscal watchdog had not altered her commitment to election pledges not to raise tax levels on earnings tax, sales tax or National Insurance.

She attributed an "uncertain world" with increasing geopolitical and trade concerns for the fiscal revenue measures, probably to be targeted on those "most able to pay."

Global Trade Tensions

Referring to apprehensions about the UK's commercial links with China she said: "The UK's national security always come first."

Recent announcement by China to strengthen trade restrictions on critical minerals and other materials that are key for high-technology manufacturing led US President Donald Trump to threaten an extra 100% import tax on goods from China, raising the prospect of an full-scale trade war between the two global powers.

The American finance chief labeled China's move "commercial pressure" and "a global supply chain power grab."

Asked about accepting the US offer to join its dispute with China, the Chancellor said she was "deeply worried" by China's actions and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the move was "harmful for the world economy and causes additional obstacles."

"In my view there are areas where we must challenge China, but there are also valuable opportunities to trade with China's economy, including banking sector and other areas of the economic system. We've got to get that balance appropriate."

The chancellor also affirmed she was collaborating with international partners "regarding our own essential resources plan, so that we are less reliant."

Health Service Medicine Costs and Funding

The Chancellor also recognized that the price the National Health Service spends on drugs could increase as a result of current discussions with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and investment.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or canceling operations in the United Kingdom, with some blaming the low prices they are getting.

Last month, the government science advisor said the cost the NHS spends on drugs would need to go up to prevent companies and pharmaceutical investment departing from the UK.

Reeves told the BBC: "We have seen as a result of the payment system, that drug testing, innovative medicines have not been provided in the UK in the extent that they are in other continental states."

"Our aim is to guarantee that patients receiving treatment from the NHS are able to obtain the top critical medicines in the world. And so we are examining all of that, and... looking to attract more funding into Britain."